Literature DB >> 21741448

RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn.

Maria Martha Papachatzaki1, Zsófia Antal, Dimitra Terzi, Péter Szücs, Venetia Zachariou, Miklós Antal.   

Abstract

The regulator of G protein signaling 9-2 (RGS9-2) is a constituent of G protein-coupled receptor (GPCR) macromolecular complexes with a major role in regulation of GPCR activity in the central nervous system. Previous in situ hybridization and Western blot studies revealed that RGS9-2 is expressed in the superficial dorsal horn of the spinal cord. In the present study, we monitored tail withdrawal latencies to noxious thermal stimuli and performed in vitro whole-cell patch clamp electrophysiological recordings from neurons in lamina II of the spinal dorsal horn to examine the role of RGS9-2 in the dorsal horn of the spinal cord in nociceptive behaviours and opiate mediated modulation of synaptic transmission. Our findings obtained from RGS9 knockout mice indicate that the lack of RGS9-2 protein decreases sensitivity to thermal stimuli and to the analgesic actions of morphine in the tail immersion paradigm. This modulatory role of RGS9-2 on opiate-mediated responses was further supported by electrophysiological studies showing that hyperpolarization of neurons in lamina II of the spinal dorsal horn evoked by application of DAMGO ([d-Ala2, N-MePhe4, Gly-ol]-enkephalin, a mu opioid receptor agonist) was diminished in RGS9 knockout mice. The results indicate that RGS9-2 enhances the effect of morphine and may play a crucial role in opiate-mediated analgesic mechanisms at the level of the spinal cord.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741448      PMCID: PMC3394093          DOI: 10.1016/j.neulet.2011.06.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Neurons with distinctive firing patterns, morphology and distribution in laminae V-VII of the neonatal rat lumbar spinal cord.

Authors:  Péter Szûcs; Francis Odeh; Karolina Szokol; Miklós Antal
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

2.  RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity.

Authors:  Shelley B Hooks; Gary L Waldo; James Corbitt; Erik T Bodor; Andrejs M Krumins; T Kendall Harden
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

3.  RGS9 modulates dopamine signaling in the basal ganglia.

Authors:  Zia Rahman; Johannes Schwarz; Stephen J Gold; Venetia Zachariou; Marc N Wein; Kwang Ho Choi; Abraham Kovoor; Ching Kang Chen; Ralph J DiLeone; Sigrid C Schwarz; Dana E Selley; Laura J Sim-Selley; Michel Barrot; Robert R Luedtke; David Self; Rachael L Neve; Henry A Lester; Melvin I Simon; Eric J Nestler
Journal:  Neuron       Date:  2003-06-19       Impact factor: 17.173

Review 4.  Mu opioid receptor: a gateway to drug addiction.

Authors:  Candice Contet; Brigitte L Kieffer; Katia Befort
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

5.  A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Authors:  Kassi Psifogeorgou; Kassi Psigfogeorgou; Dimitra Terzi; Maria Martha Papachatzaki; Artemis Varidaki; Deveroux Ferguson; Stephen J Gold; Venetia Zachariou
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

6.  Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain.

Authors:  S J Gold; Y G Ni; H G Dohlman; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

7.  Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.

Authors:  Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

8.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

9.  Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5.

Authors:  Ching-Kang Chen; Pamela Eversole-Cire; Haikun Zhang; Valeria Mancino; Yu-Jiun Chen; Wei He; Theodore G Wensel; Melvin I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

10.  The contribution of autophosphorylated alpha-calcium-calmodulin kinase II to injury-induced persistent pain.

Authors:  K P Zeitz; K P Giese; A J Silva; A I Basbaum
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  9 in total

1.  RGS9-2 modulates sensory and mood related symptoms of neuropathic pain.

Authors:  Dimitra Terzi; Sevasti Gaspari; Lefteris Manouras; Giannina Descalzi; Vassiliki Mitsi; Venetia Zachariou
Journal:  Neurobiol Learn Mem       Date:  2014-08-19       Impact factor: 2.877

2.  Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction.

Authors:  David L Roman; John R Traynor
Journal:  J Med Chem       Date:  2011-09-29       Impact factor: 7.446

Review 3.  μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  John Traynor
Journal:  Drug Alcohol Depend       Date:  2011-11-29       Impact factor: 4.492

4.  Regulators of G-Protein Signaling (RGS) Proteins Promote Receptor Coupling to G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels.

Authors:  Kylie B McPherson; Emily R Leff; Ming-Hua Li; Claire Meurice; Sherrica Tai; John R Traynor; Susan L Ingram
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

5.  RGS4 Maintains Chronic Pain Symptoms in Rodent Models.

Authors:  Kleopatra Avrampou; Kerri D Pryce; Aarthi Ramakrishnan; Farhana Sakloth; Sevasti Gaspari; Randal A Serafini; Vasiliki Mitsi; Claire Polizu; Cole Swartz; Barbara Ligas; Abigail Richards; Li Shen; Fiona B Carr; Venetia Zachariou
Journal:  J Neurosci       Date:  2019-07-15       Impact factor: 6.167

6.  Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.

Authors:  Jennifer T Lamberts; Chelsea E Smith; Ming-Hua Li; Susan L Ingram; Richard R Neubig; John R Traynor
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

7.  RGS10 exerts a neuroprotective role through the PKA/c-AMP response-element (CREB) pathway in dopaminergic neuron-like cells.

Authors:  Jae-Kyung Lee; Jaegwon Chung; Kirk M Druey; Malú G Tansey
Journal:  J Neurochem       Date:  2012-05-30       Impact factor: 5.372

Review 8.  Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.

Authors:  Nicolas B Senese; Ram Kandasamy; Kelsey E Kochan; John R Traynor
Journal:  Front Mol Neurosci       Date:  2020-01-24       Impact factor: 5.639

Review 9.  Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway.

Authors:  Kylie B McPherson; Susan L Ingram
Journal:  Front Syst Neurosci       Date:  2022-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.